Literature DB >> 6796152

Regulation of hepatic lipogenesis in starved and diabetic animals by thyroid hormone.

M C Sugden, D I Watts, C E Marshall.   

Abstract

The effects of intragastric feeding with glucose and of the administration of L-triiodothyronine (T3) on in vivo rates of hepatic lipogenesis were investigated in control (fed ad libitum on normal diet), diabetic (fed ad libitum on normal diet), fat-fed (fed ad libitum on high-fat diet), and starved (food removed for 48 h) rats. Two days of T3 treatment increased hepatic lipogenesis in control and fat-fed animals but not in the diabetic or starved animals, although increases in lipogenesis in diabetic animals were observed after 4 days of T3 treatment. Intragastric glucose feeding increased hepatic lipogenesis in the livers of control animals and T3-treated control animals. Such increases are mediated by an increase in the circulating insulin concentration, as increases are not observed in diabetic rats or T3-treated diabetic rats. Glucose feeding failed to increase hepatic lipogenesis in fat-fed rats or starved rats. Insulin injection together with glucose feeding increased lipogenesis in the fat-fed group but not the starved group; i.e., impaired insulin secretion following an oral glucose load may in part explain the lack of response in the fat-fed but not the starved animals. Marked increases in hepatic lipogenesis after glucose feeding were, however, observed if either the starved or the fat-fed animals were treated with T3. The physiological implications of these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796152     DOI: 10.1007/BF01114797

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  11 in total

1.  Glucose utilization by skeletal muscles in vivo in experimental hyperthyroidism in the rat.

Authors:  M C Sugden; Y L Liu; M J Holness
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

2.  A tissue-specific increase in lipogenesis in rat brown adipose tissue in hypothyroidism.

Authors:  H S Baht; E D Saggerson
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

3.  Thyroid hormone action on intermediary metabolism. Part II: Lipid metabolism in hypo- and hyperthyroidism.

Authors:  M J Müller; H J Seitz
Journal:  Klin Wochenschr       Date:  1984-01-16

4.  Regulation of hepatic fructose 2,6-bisphosphate concentrations and lipogenesis after re-feeding in euthyroid and hyperthyroid rats. A regulatory role for glycogenesis.

Authors:  M J Holness; E B Cook; M C Sugden
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

5.  Hepatic carbon flux after re-feeding. Hyperthyroidism blocks glycogen synthesis and the suppression of glucose output observed in response to carbohydrate re-feeding.

Authors:  M J Holness; M C Sugden
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

6.  The relationship between fat synthesis and oxidation in the liver after re-feeding and its regulation by thyroid hormone.

Authors:  M J Holness; T J French; P S Schofield; M C Sugden
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

7.  Continued glucose output after re-feeding contributes to glucose intolerance in hyperthyroidism.

Authors:  M J Holness; M C Sugden
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

8.  Interactions between insulin and thyroid hormone in the control of lipogenesis.

Authors:  M C Sugden; S E Steare; D I Watts; T N Palmer
Journal:  Biochem J       Date:  1983-03-15       Impact factor: 3.857

9.  Regulation of renal and hepatic pyruvate dehydrogenase complex on carbohydrate re-feeding after starvation. Possible mechanisms and a regulatory role for thyroid hormone.

Authors:  M J Holness; M C Sugden
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

Review 10.  The regulation of ApoB metabolism by insulin.

Authors:  Mary E Haas; Alan D Attie; Sudha B Biddinger
Journal:  Trends Endocrinol Metab       Date:  2013-05-27       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.